Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy

Urology

Volumn 61, Issue 1, 2003, Pages 152-155

  Elshaikh, Mohamed A ^a,b   Angermeier, Kenneth ^a,b   Ulchaker, James C ^a,b   Klein, Eric A ^a,b   Chidel, Mark A ^a,b   Mahoney, Stephen ^a,b   Wilkinson, D Allan ^a,b   Reddy, Chandana A ^a,b   Ciezki, Jay P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Kaiser Permanente ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

AGED; ANATOMY; ARTICLE; BRACHYTHERAPY; CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; HUMAN; IMPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY; URINE RETENTION;

AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SELF CARE; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 0037256368     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02142-8     Document Type: Article

References (13)

1. Ragde H., Blasko J., Grimm P., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 80:1997;442-453.
2. Ragde H., Korb L., Elgamal A., et al. Modern prostate brachytherapy prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer. 89:2000;135-141.
3. D'Amico A., Whittington R., Malkowicz S., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:1998;969-974.
4. Blasko J., Ragde H., Grimm P. Transperineal ultrasound-guided implantation of the prostate morbidity and complications. Scand J Urol Nephrol Suppl. 137:1991;113-118.
5. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 28:1994;985-990.
6. Terk M., Stock R., Stone N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 160:1998;1379-1382.
7. Benoit R., Naslund M., Cohen J. A comparison of complications between ultrasound-guided prostate brachytherapy and open prostate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;909-913.
8. Lee N., Wuu C., Brody R., et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 48:2000;1457-1460.
9. Crook J., McLean M., Catton C., et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys. 52:2002;453-460.
10. Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy a prospective study. Int J Radiat Oncol Biol Phys. 52:2002;712-719.
11. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 44:1999;789-799.
12. Nag S., Bice W., DeWyngaert J., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46:2000;221-230.
13. Nag S., Ciezki J., Cormack R., et al. Intraoperative planning and evaluation of permanent prostate brachytherapy report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 51:2001;1422-1430.